Aaron Gentzler is the publisher of Seven Figure Publishing. He is also the editor of The Rundown and has been with Agora Financial / Seven Figure Publishing since 2005. He's been covering technology and markets for over a decade.
The FDA expedited emergency approval for Gilead Sciences’ remdesivir on May 1; this morning GILD shares are moving up and to the right.
Even with the stock market on a Fed sugar high, we think this might be the week for gold to shine.
Similarities between the Fed’s behavior during World War II and the corona-crash might be an indicator of what happens next -- particularly when it comes to gold.